The erbB2/HER2/neu receptor polymorphism Ile655Val and breast cancer risk-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The erbB2/HER2/neu receptor polymorphism Ile655Val and breast cancer risk

Published:2005-07 Issue:7 Volume:15 Page:447-450
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Cox David G.,Hankinson Susan E.,Hunter David J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference21 articles.

1. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001

2. A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma;Semba;Proc Natl Acad Sci USA,1985

3. Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line;Fukushige;Mol Cell Biol,1986

4. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab;Cho;Nature,2003

5. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions;Pinkas-Kramarski;EMBO J,1996

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between HER2 (Ile655Val) polymorphism with risk of breast cancer: An extensive meta-analysis;Human Gene;2024-05

2. HER2Ile655Val Polymorphism and Risk of Breast Cancer;Genetic Polymorphisms - New Insights [Working Title];2021-08-21

3. Assessment of circulating miR-20b, miR-221, and miR-155 in occupationally lead-exposed workers of North-Western India;Environmental Science and Pollution Research;2020-09-09

4. Human Epidermal Growth Factor Receptor-2 gene polymorphism and breast cancer risk in women from the Northeastern region of Brazil;Clinics;2020

5. Her2 Ile655Val polymorphism and its association with breast cancer risk: an updated meta-analysis of case-control studies;Scientific Reports;2018-05-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3